Genpharm and Apellis Pharmaceuticals Enter in an Exclusive Agreement

October 7, 2022

Genpharm Joins MassBio

January 20, 2022

argenx and Genpharm Sign Exclusive Commercial and Distribution Agreement

January 11, 2022

Amicus Therapeutics and Genpharm Services Sign Distribution Agreement for the Treatment of Amenable Patients Living with Fabry Disease

Genpharm Enters into Agreement with Albireo Pharma

January 20, 2021

Genpharm Enters into Agreement with Orchard Therapeutics

October 15, 2020

Genpharm features in Rare Revolution Magazine

Genpharm is proud to announce the appointment of Mr. Mark Rothera to the company’s executive board

Genpharm enters into Commercial Agreement with Ultragenyx for the Middle East Region

Shedding lights and raising awareness on Rare Disease in the Middle East

Genpharm signs with Biohaven Pharmaceuticals

The Rise of Professional Market Access Navigators

Genpharm partners with Rare Revolution Magazine

February 6, 2020

Genpharm 2.0 – An Interview by PharmaBoardroom.

December 30, 2019

The Case for Rare Disease Clinical Trials in the Middle East

November 20, 2019

Genpharm Initiates Gene Therapy for SMA Patients in Kuwait & Qatar

October 17, 2019

Genpharm sponsors First Myology Teaching Course in MENA

October 2, 2019

Karim Smaira: A Leader with a Commitment to Serve

September 1, 2019

Top 50 most trustworthy companies of the year 2019 by The Silicon Review®

February 18, 2019

Genpharm partners with UAE Rare Disease Society

December 7, 2018

Genpharm: A Foremost Pharmaceutical Organization Offering Tailor-made and Comprehensive Solutions

November 21, 2018

Santhera Enters into Agreement to Acquire Option from Idorsia for Exclusive Sub-License of First-in-class Dissociative Steroid Vamorolone for Duchenne Muscular Dystrophy (DMD)

Genpharm Incorporates European Entity in Ireland

November 12, 2017

Partner News: Progenity Raises $125M in Series B Financing to Advance Dx-Rx Platform for GI Tract

Genpharm Announces the launch of its Primary Care Unit

Aspire Educational Series: Dermatomyositis- Part 21

Aspire Educational Series: Central Core Disease (CCD) – Part 20

A Key Learning from the Late Henri TermeerPublished on May 16, 2017 By Karim Smaira (Genpharm co-founder and CEO)

Pharma Outlook in the MENA region: an insider’s view

Aspire Educational Series: Distal Muscular Dystrophy- Party 19

Aspire Educational Series: Limb Girdle Muscular Dystrophy- Part 18

Aspire Educational Series: Oculopharyngeal Muscular Dystrophy (OPMD)- Part 17

Genpharm employees rejoice in Lebanon

Aspire Educational Series: Facioscapulohumeral Muscular Dystrophy (FSHD)- Par t16

Under the patronage of HE Dr. Aisha Mubarak Bu Unuq, Genpharm sponsoring the annual Family Day for definition of Genetic Metabolic Diseases in Bahrain

Entrepreneur Magazine Middle East, March 2016

Featured in Life Science Leader Magazine: The MENA Pharma Market an Untapped Opportunity

Aspire Educational Series: Becker Muscular Dystrophy (BMD)- Part 15

Aspire Educational Series: Congenital Muscular Dystrophy (CMD)- Part 14

Aspire Educational Series: Mitochondrial Myopathy (MM)- Part 13

Aspire Educational Series-Emery: Dreifuss Muscular Dystrophy (EDMD)- Part 12

Aspire Educational Series: Myotonic Dystrophy (MD)- Part 11

His Excellency Sheikh Nahyan bin Mubarak Al Nahyan honoring Genpharm for their role in raising awareness on Rare Disease and for their contribution on Rare Disease Day

Aspire Educational Series: Spinal-Bulbar Muscular Atrophy (SBMA)- Part 10

February 28, 2017

COMPANY ANNOUNCEMENT; Admedus and Genpharm get approval & first sales in Saudi Arabia

February 23, 2017

Princess Al-Jawhara Center for Molecular Medicine of the University of the Arabian Gulf in cooperation with Genpharm conducted a lecture on the latest updates on Genetic Myopathies

February 20, 2017

Partner News: Augusto Mitidieri, Sintetica CEO awarded Best European CEO for 2016

February 20, 2017

ASPIRE Educational Series: Charcot-Marie-Tooth Disease (CMT)- Part 9

February 19, 2017

The National- News: Young Arabs could benefit from UAE genes discovery

February 12, 2017

ASPIRE Educational Series: Pompe Disease- Part 8

February 2, 2017

ASPIRE Educational Series: Myasthenia Gravis (MG)- Part 7

January 29, 2017

Aspire Educational Series: Amyotrophic Lateral Sclerosis (ALS)- Part 6

January 24, 2017

ASPIRE Educational Series: Friedreich’s Ataxia (FA)- Part 5

January 24, 2017

ASPIRE Educational Series: GNE Myopathy- Part 4

December 27, 2016

ASPIRE Educational Series- Spinal Muscular Atrophy (SMA)- Part 3

December 20, 2016

ASPIRE Educational Series- An Introduction to Duchenne Muscular Dystrophy (DMD)- Part 2

December 14, 2016

Genpharm AWARDED THE MEA MARKETS 2016 best Pharmaceutical company

December 12, 2016

PTC Therapeutics Receives France’s 2016 Prix Galien for Translarna™

December 12, 2016

ASPIRE educational series: What is a NeuroMuscular Disease (NMD)- Part 1

December 6, 2016

The First Global Paediatric Conference

November 21, 2016

CARDIOCEL® RECEIVES MARKET APPROVAL IN UAE

November 21, 2016

Genpharm embarks on a public campaign to raise awareness on Duchenne Muscular Dystrophy (DMD)

November 16, 2016

Study over 2,200 patients confirms high accuracy of PrenaTest® for fetal trisomies

November 10, 2016

Genpharm Sponsoring at the WORLD SOCIETY FOR PEDIATRIC AND CONGENITAL HEART SURGERY- WSPCHS

November 10, 2016

Genpharm supporting the 6th International Genetic Disorders Conference

Boston CEO and Bio Meetings, USA

Boston, 2nd of June 2016

Genpharm Awards Outstanding Employees for 2015

February 29, 2016

Genpharm is the proud sponsor of the 1st Paediatric Neurology Society

February 29, 2016

Genpharm 2016 Cycle Meeting

February 29, 2016

To Mark 2016 Rare Disease Day in MENA

February 11, 2016

The A to Z of how medicines are developed

February 4, 2016

Genpharm First Sales of CardioCel in the Middle East and North African (MENA) region

October 22, 2015

Genpharm and randstad

October 7, 2015

Genpharm features in CEO REPORT GULF2020: MENA Orphan Drug Sector expected to boom

September 29, 2015

Join LAND for Hope: a support group for Duchenne Muscular Dystrophy patients in the MENA region

September 22, 2015

Genpharm Awards First Marquee Employee

September 16, 2015

Medical Experts Gather to Discuss Neuropharmagen and Pharmacogenetic Advances in CNS

The BIO International Convention in Philadelphia – June 15th to 18th.

Genpharm & AB Biotics Partner to Commercialize Neuropharmagen® in MENA

Genpharm opens offices in the Boston Biotech Hub

Genpharm and Admedus Partner to commercialize CardioCel® in the MENA region

Genpharm and Genzyme extend their on-going collaboration in the field of MS

January 10, 2015

Genpharm Announces New Executive Board

January 4, 2015

Genpharm Awards Best Achiever for 2014

December 22, 2014

Genpharm 2014 Annual Meeting

December 10, 2014

Genpharm Inaugurates regional office in Dubai’s Business Bay

October 20, 2014

Genpharm and Genzyme Launch the 1st ASPIRE MS Research Grant in Middle East

September 1, 2014

Genpharm Expands into Women’s Health and Fertility with Finox Agreement

August 24, 2014

Genpharm supports fund-raising event for the Lebanese MS Patient Association.

Finox & Save the Children Announce €0.10 donation for every Bemfola®

The BIO International Convention in San Diego – June 23rd to 26th.

Genpharm Extends collaboration with World Orphan Drug Congress(WODC)

January 5, 2014

Sintetica & Genpharm sign Baclofen® agreement for Middle East

December 12, 2013

MENA Biotechnology & Biosimilars Forum

November 28, 2013

Gulf News Leadership 2014 Magazine Features Genpharm

November 21, 2013

Aspire 2013

November 17, 2013

Orphan Drug Meeting in Europe

October 23, 2013

Pharmaceutical Executive Features Genpharm: Focus Interview

October 5, 2013

The Arab Business Club hosted its first Annual Healthcare Summit

September 19, 2013

Middle East Pharma Markets Continue to Soar: Here’s Why?

September 1, 2013

EC approves AUBAGIO® for use in RMS

Genpharm and Genzyme Aubagio ® agreement for the MENA region

Juxtapid Sales Soar

Orphan Drug Market Shows Steady Growth

Prenatest studies: Early prenatal diagnosis at higher accuracy of 99.8%

The 4th Annual Orphan Drug Meeting Europe

Multiyear agreement with Aegerion Pharmaceuticals

Genpharm supports World Multiple Sclerosis Day

1st Multiple Sclerosis Update in the UAE

Orphan Drug Meeting USA 2013

Middle East Obstetric and Gynecology Congress in Dubai

Genpharm Adopts Its Corporate Values

February 28, 2013

Prenatest® Launched During Rare Disease Day in Bahrain

February 27, 2013

Stallergenes SA and Genpharm Services Extend Collaboration to Egypt

February 20, 2013

6th Rare Disease Day on February 28th, 2013

February 1, 2013

An Attractive Opportunity for Rare Disease and Healthcare Companies

December 31, 2012

Genpharm Joins the Swiss Biotech Association

December 26, 2012

Genpharm Sponsors the Orphan Drug Meeting USA 2013

December 24, 2012

Genpharm Raises Awareness on Allergic Rhinitis and Allergic Asthma

December 23, 2012

Genpharm Innovates at the Emirates Obs-Gyne & Fertility Forum 2012

December 20, 2012

Genpharm, LifeCodexx and Biogen Medical Agree to Launch Prenatest

December 4, 2012

Genpharm at the 33rd Annual SICOT Gathering

December 3, 2012

Genpharm at the 3rd Annual World Orphan Drug Congress

November 19, 2012

Genpharm at Eye for Pharma EM Summit

November 13, 2012

Genpharm Signs Agreement for Commercialization of ChondroCelect

October 29, 2012

Stallergenes SA and Genpharm Services

October 24, 2012

Emirati-Swiss Friendship Council Meet

October 6, 2012

Leadership Deep Dive

September 8, 2012

Website Launch